Skip to main content

Table 1 Baseline characteristics

From: Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial

 

Preschool-aged children (PSAC)

School-aged children (SAC)

Treatment arm

Treatment arm

Characteristics

Placebo

20 mg/kg

40 mg/kg

60 mg/kg

Placebo

20 mg/kg

40 mg/kg

60 mg/kg

42

40

44

44

38

46

46

44

Female N (%)

23 (54.8)

21 (52.5)

20 (45.5)

27 (61.4)

23 (60.5)

25 (54.3)

25 (54.3)

25 (56.8)

Age, years; median

4

4

4

4

9

8

8

9

[IQR]

[2–5]

[2–5]

[2–5]

[2–5]

[6–13]

[6–13]

[6–14]

[6–13]

Weight, kg; median

15

15

15

15

22

22

24

22

[IQR]

[10–21]

[11–19]

[11–19]

[11–18]

[18–35]

[18–33]

[18–38]

[18–40]

Height, cm; median

97

98

101

100

125

125

125

124

[IQR]

[80–117]

[83–115]

[84–116]

[83–114]

[109–141]

[114–139]

[113–149]

[112–150]

Haemoglobin (g/dL); median

10.5

11.0

10.9

10.9

11.4

11.2

11.7

11.6

[IQR]

[9.1–13.2]

[9.1–12.8]

[8.8–12.5]

[8.5–12.9]

[9.7–13.7]

[9.9–12.4]

[9.7–12.8]

[10.1–13.5]

Infection intensity N (%)

 Light

36 (85.7)

38 (95.0)

38 (86.4)

40 (90.9)

27 (71.1)

35 (76.1)

36 (78.3)

33 (75.0)

 Heavy

6 (14.3)

2 (5.0)

6 (13.6)

4 (9.1)

11 (28.9)

11 (23.9)

10 (21.7)

11 (25.0)

Co-infections N (%)

S. mansoni

0 (0.0)

0 (0.0)

1 (2.3)

1 (2.3)

0 (0.0)

1 (2.2)

1 (2.2)

0 (0.0)

Plasmodium falciparum

1 (2.4)

0 (0.0)

1 (2.3)

0 (0.0)

1 (2.6)

4 (8.7)

2 (4.3)

3 (6.8)

 (based on thin/thick smear)

  1. IQR interquartile range